Related Experiment Video

Updated: Aug 13, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

MKP-8, a novel MAPK phosphatase that inhibits p38 kinase

Sanjeev A Vasudevan1, John Skoko, Kuan Wang

  • 1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA.

Biochemical and Biophysical Research Communications
|March 31, 2005
PubMed

Insights

Researchers discovered a new protein phosphatase, mitogen-activated protein kinase phosphatase-8 (MKP-8), which is highly expressed in embryonal cancers. MKP-8 regulates key signaling pathways involved in cancer progression.

Area of Science:

  • Cancer Biology
  • Molecular Biology
  • Cell Signaling

Background:

  • Intracellular signaling pathways are critical in understanding malignant progression.
  • The dual-specificity phosphatase (DSP) family regulates signaling pathways.
  • Novel DSPs are actively being identified and characterized.

Purpose of the Study:

  • To identify and characterize a novel protein phosphatase with DSP activity.
  • To determine the expression pattern and cellular localization of the novel phosphatase.
  • To investigate the phosphatase activity and regulatory role in mitogen-activated protein kinase (MAPK) signaling.

Main Methods:

  • Bioinformatic analysis to identify conserved catalytic and MKP motifs.
  • Protein expression and localization studies using cell culture.
  • Enzyme activity assays to measure phosphatase function.
  • Co-expression studies with activated MAPKs to assess inhibitory effects.

Main Results:

  • A novel protein, named mitogen-activated protein kinase phosphatase-8 (MKP-8), was identified, possessing DSP and MKP motifs.
  • MKP-8 is a ~20kDa protein primarily localized to the cell nucleus.
  • MKP-8 exhibits significant phosphatase activity, which is dependent on its catalytic domain.
  • MKP-8 expression is elevated in embryonal cancers (retinoblastoma, neuroepithelioma, neuroblastoma) with limited normal tissue expression.
  • MKP-8 inhibits p38 kinase phosphorylation and downstream signaling when co-expressed with activated MAPKs.

Conclusions:

  • MKP-8 is a novel nuclear-localized DSP with significant phosphatase activity.
  • MKP-8 expression is associated with embryonal cancers, suggesting a role in tumorigenesis.
  • MKP-8 negatively regulates p38 MAPK signaling, indicating its potential involvement in cancer progression.

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...